Cite
HARVARD Citation
Kassir, N. et al. (2022). Exposure‐response relationships of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis. CPT: pharmacometrics & systems pharmacology. pp. 1234-1243. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kassir, N. et al. (2022). Exposure‐response relationships of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis. CPT: pharmacometrics & systems pharmacology. pp. 1234-1243. [Online].